Brought to you by 
VitaResc acquires septic shock drug developer Apex Bioscience
03 Feb 2000
Executive Summary
VitaResc Biotech AG, a recently formed German company, acquired Research Triangle, NC-based Apex Bioscience (hemoglobin and nitric oxide technologies) . Apex merged with a newly formed US division of VitaResc; the merged division will keep the Apex name, and its staff will remain the same.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Intra-Biotech Deal
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
VitaResc acquires septic shock drug developer Apex Bioscience
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice